Methacycline is more quickly absorbed and possibly more slowly cleared than tetracycline; it has a longer duration of action and it produces higher serum levels and higher antibacterial levels in vitro (Kunin, 1962; Remington and Finland, 1962; Te-Wen Chang and Weinstein, 1962; Limson and Guevara, 1963) . To determine whether it might be more effective than tetracycline in the treatment of non-specific urethritis, the two drugs were compared in a double-blind clinical trial. Patients were asked not to take capsules within 2 hours of a meal (Kirby, Roberts, and Bardick, 1961) and to refrain from sexual activity and drinking alcohol while under surveillance. Follow-up attendances varied with the progress in each case. When persistence or recurrence of urethritis was recognized; cases were re-treated with the same double-blind procedure. At the conclusion of the trial the type of drug given to each patient at the initial or secondary treatmnent was revealed to the physician and the results were assessed on the basis of the recorded findings at 1 week, and 1, 2, and 3 months after starting treatment. The criteria for "cure" were the cessation of symptoms and the absence of urethral discharge coupled with a clear voided urine held for 5 hours (Harkness, 1950) . No attention was paid to clear urethral secretion, early morning smears containing only occasional leucocytes, or to urine containing mucus. Cases of presumed relapse were not distinguished from those of presumed re-infection-both were classed as failure of treatment.
Methacycline is more quickly absorbed and possibly more slowly cleared than tetracycline; it has a longer duration of action and it produces higher serum levels and higher antibacterial levels in vitro (Kunin, 1962; Remington and Finland, 1962; Te-Wen Chang and Weinstein, 1962; Limson and Guevara, 1963) . To determine whether it might be more effective than tetracycline in the treatment of non-specific urethritis, the two drugs were compared in a double-blind clinical trial.
Material and Methods
Patients with obvious discharge were chosen so as to allow more clear-cut evidence of cure or failure. The following were excluded: patients with a history of hepatic, renal, or bowel disease; those in whom urethritis had been treated in the last 6 months or who had taken antibiotics for some other reason; and those with limited ability to understand English. A total of 66 men with non-specific urethritis, in one case complicated by Reiter's disease, entered the trial. Gonorrhoea and Trichomonas vaginalis urethritis were excluded on the results of Gram-stained smears and culture of the urethral discharge and on findings in wet smears.
Alternate cases were treated with methacycline, the others with tetracycline; the drugs were supplied in identical form, each patient being instructed to take two capsules every 8 hours for 5 days. Each dose of methacycline was of 300 mg; that of tetracycline was 500 mg.
Patients were asked not to take capsules within 2 hours of a meal (Kirby, Roberts, and Bardick, 1961) and to refrain from sexual activity and drinking alcohol while under surveillance. Follow-up attendances varied with the progress in each case. When persistence or recurrence of urethritis was recognized; cases were re-treated with the same double-blind procedure. At the conclusion of the trial the type of drug given to each patient at the initial or secondary treatmnent was revealed to the physician and the results were assessed on the basis of the recorded findings at 1 week, and 1, 2, and 3 months after starting treatment. The criteria for "cure" were the cessation of symptoms and the absence of urethral discharge coupled with a clear voided urine held for 5 hours (Harkness, 1950) . No attention was paid to clear urethral secretion, early morning smears containing only occasional leucocytes, or to urine containing mucus. Cases of presumed relapse were not distinguished from those of presumed re-infection-both were classed as failure of treatment.
Results
Three of those taking methacycline suffered nausea and one other mild diarrhoea; in all the remaining cases there were no reports of side-effects.
All 66 cases could be assessed at the first week, but by the completion of the trial 31 per cent. of the patients had defaulted.
The results at each period of assessment are shown in Table I 
Discussion
The negligible difference in response to the two drugs is hardly surprising when it is taken into account that more methacycline than tetracycline is rendered inert by being protein-bound, despite producing a higher serum level.
Thus Kunin (1962) showed experimentally that 35-6 per cent. of tetracycline and 78-5 per cent. of methacycline became protein-bound. Te-Wen Chang and Weinstein (1962) showed that there was decreased anti-bacterial activity of antibiotic if incubated in vitro with serum, and English (1966) showed that the percentage inactivation corresponded with the theoretical prediction of proteinbinding. The percentage inactivation of methacycline was 81 per cent. and that of tetracycline 59 per cent. Thus the apparent increased methacycline levels may be less active than anticipated and the prolonged presence of the drug in body fluids merely reflects its protein-binding propensity coupled with a slow release. In this respect it is interesting to note that, if tetracycline is given to patients with hypoproteinaemia, the normal dose may have a toxic action upon them, for example, a catabolic effect and liver toxicity. The state of nutrition of the patients in the present series was excellent and the toxic effects were negligible.
Comparisons should not be drawn between the results recorded in the present trial and those in a recent trial of methacycline in non-specific urethritis (Morton and Wray, 1966) , as the latter trial was uncontrolled and a different dosage was employed.
The tetracycline dosage used in the present trial seems to have had a suppressive rather than a curative action, in that the major signs of the disease were quickly reversed but the minimal signs continued. In nineteen out of 28 of the cases of failure there was persistence of many leucocytes in early morning urethral smears.
This action may relate to the fact that TRIC agent is the cause of some cases of non-specific urethritis. Jawetz (1964) , quoting Watkins, observed that " . . . tetracycline is not viricidal and has no effect on TRIC agent in vitro in the absence of host cells, but it inhibits the growth and formation of their lethal products". Une experience control6e de 1'emploi de la m6thacycline et de la t6tracycline dans le traitement de P'ur6trite non-sp6cifique RESUME 66 malades atteints d'uretrite non-specifique ont pris part a une experience de traitement a double insu par la methacycline et la tetracycline, ces medicaments etant donnes en doses equivalentes pour un traitement de 5 jours. Les taux cumulatifs d'insucces etaient presqu'identiques. Les meilleurs taux estimes de cure etaient de 67 pour cent pour la t6tracycline et de 50 pour cent pour la methacycline, mais cette difference n'est pas statistiquement significative. La raison offerte pour expliquer pourquoi la methacycline n'est pas superieure a la tetracycline est que les effets des taux accrus de la methacycline dans le serum sont probablement neutralises par la liaison avec les proteines. Le mode d'action de la tetracycline est probablement d'attenuer la maladie plutot que de la guerir. On pense que dans les exp6riences a venir, le taux serique devrait 6tre estime afin de prendre en consid6ration les diff6r-ents d6gr6s d'absorption.
